Baricitinib

Updates with regard to its use in COVID-19

25 Likes

LikeAnswersShare

Encouraging results of Baricitinib in HD group suggest it should be a choice in place of Tocilizumab But in case studies it was included only after cytokine storm on 12 to 14 days Still more work is to be done

Thanx dr Ashok Leel
0

View 6 other replies

Baricitinib should be a choice in place of Tocilizumab but clinically needed more research and assessment and evaluation to be on the top priority. Time period of infusion may also needs some more consideration. Good informative and educative post needs further information.

Thanks Dr Ved Prakash Singh
1

View 3 other replies

Nice combination therapy .. Baricitinib is use in Reumtoid arthritis .In Covid pandamic positive severe cases combination with Dexamethasone , combination with remedisvir use as very positive and good results . Thanks for sharing with us.

Nice drugs information.. Uploaded.. Baricitinib in covid 19 cases.. Antineoplastic and immunomodulatory agent.. High dose case of pneumonia.. Nicely explain..

Thanks doctor
0

Is it in trial phase??

Very nice and useful updates. Thanks for sharing useful information

Impressive More studies

Doctors call to use this baricitinib Crystal clear presentation

उत्तम अति उत्तम

Load more answers

Diseases Related to Discussion

Cases that would interest you